These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 329978

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined therapy with bleomycin and some immunological implications.
    Barduagni A, Marolla A, Calabresi F, Terzoli E.
    Prog Biochem Pharmacol; 1976; 11():185-94. PubMed ID: 63963
    [No Abstract] [Full Text] [Related]

  • 3. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW, Maurice P, Sonntag RW.
    Schweiz Med Wochenschr; 1972 Oct 28; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M, Teillet F, Weisgerber C, Dana M, Jacquillat C, Bernard J.
    Rev Prat; 1974 Oct 11; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract] [Full Text] [Related]

  • 5. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
    Nissen NI, Stutzman L, Holland JF, Glidewell OJ.
    Arch Intern Med; 1973 Mar 11; 131(3):396-401. PubMed ID: 4688038
    [No Abstract] [Full Text] [Related]

  • 6. Combination chemotherapy in Hodgkin's disease.
    Nordentoft AM, Jensen KB.
    Dan Med Bull; 1973 Mar 11; 20(2):52-60. PubMed ID: 4688460
    [No Abstract] [Full Text] [Related]

  • 7. Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
    Durant JR, Bartolucci A, Gams RA, Dorfman RF, Velez-Garcia E.
    Cancer Treat Rep; 1976 Jun 11; 60(6):781-7. PubMed ID: 782700
    [Abstract] [Full Text] [Related]

  • 8. [Chemotherapy of Hodgkin's disease].
    Amiel JL, Mathé G.
    Rev Prat; 1974 Oct 11; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
    [No Abstract] [Full Text] [Related]

  • 9. Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
    Rubin P.
    JAMA; 1973 Jan 08; 223(2):164-6. PubMed ID: 4739455
    [No Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP, Young RC, Berard CW, DeVita VT.
    Arch Intern Med; 1973 Mar 08; 131(3):388-90. PubMed ID: 4569375
    [No Abstract] [Full Text] [Related]

  • 11. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT.
    Natl Cancer Inst Monogr; 1973 May 08; 36():373-9. PubMed ID: 4744596
    [No Abstract] [Full Text] [Related]

  • 12. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1983 May 08; 67(5):413-9. PubMed ID: 6342771
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
    Luce JK, Frei E, Gehan EA, Coltman CA, Talley R, Monto RW.
    Arch Intern Med; 1973 Mar 08; 131(3):391-5. PubMed ID: 4688037
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ, Wrigley PF, Hunter A, Crowther D, Malpas JS, Peckham MJ, Smithers DW, Fairley GH.
    Natl Cancer Inst Monogr; 1973 May 08; 36():395-402. PubMed ID: 4744597
    [No Abstract] [Full Text] [Related]

  • 16. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E, Kende G, Many A, Ramot B.
    Harefuah; 1974 Apr 01; 86(7):348-51. PubMed ID: 4846045
    [No Abstract] [Full Text] [Related]

  • 17. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN, Gregory W, Hudson GV, Devereux S, Goldstone AH, Hancock B, Winfield D, MacMillan AK, Hoskin P, Newland AC, Milligan D, Linch DC.
    Br J Cancer; 1999 Oct 01; 81(3):476-83. PubMed ID: 10507773
    [Abstract] [Full Text] [Related]

  • 18. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH.
    N Engl J Med; 1974 Dec 12; 291(24):1309. PubMed ID: 4431438
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.